rs534510177
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_017780.4(CHD7):c.7199G>A(p.Arg2400Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,588,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152026Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000432 AC: 1AN: 231476Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 125588
GnomAD4 exome AF: 0.0000195 AC: 28AN: 1436830Hom.: 0 Cov.: 31 AF XY: 0.0000168 AC XY: 12AN XY: 713728
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152142Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74374
ClinVar
Submissions by phenotype
CHD7-related disorder Uncertain:1
The CHD7 c.7199G>A variant is predicted to result in the amino acid substitution p.Arg2400Gln. This variant was reported as a variant of uncertain significance in an individual with normosmic congenital hypogonadotropic hypogonadism, however no additional studies were done to test its pathogenicity (Cassatella et al. 2018. PubMed ID: 29419413). This variant is reported in 0.0069% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
CHARGE syndrome Benign:1
- -
CHARGE syndrome;C3552553:Hypogonadotropic hypogonadism 5 with or without anosmia Other:1
Variant interpreted as Uncertain significance and reported on 03-26-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at